361 research outputs found
Dusty star forming galaxies at high redshift
The global star formation rate in high redshift galaxies, based on optical
surveys, shows a strong peak at a redshift of z=1.5, which implies that we have
already seen most of the formation. High redshift galaxies may, however, emit
most of their energy at submillimeter wavelengths if they contain substantial
amounts of dust. The dust would absorb the starlight and reradiate it as
far-infrared light, which would be redshifted to the submillimeter range. Here
we report a deep survey of two blank regions of sky performed at submillimeter
wavelengths (450 and 850-micron). If the sources we detect in the 850-micron
band are powered by star formation, then each must be converting more than 100
solar masses of gas per year into stars, which is larger than the maximum star
formation rates inferred for most optically-selected galaxies. The total amount
of high redshift star formation is essentially fixed by the level of background
light, but where the peak occurs in redshift for the submillimeter is not yet
established. However, the background light contribution from only the sources
detected at 850-micron is already comparable to that from the
optically-selected sources. Establishing the main epoch of star formation will
therefore require a combination of optical and submillimeter studies.Comment: 10 pages + 2 Postscript figures, under embargo at Natur
Controlling passively-quenched single photon detectors by bright light
Single photon detectors based on passively-quenched avalanche photodiodes can
be temporarily blinded by relatively bright light, of intensity less than a
nanowatt. I describe a bright-light regime suitable for attacking a quantum key
distribution system containing such detectors. In this regime, all single
photon detectors in the receiver Bob are uniformly blinded by continuous
illumination coming from the eavesdropper Eve. When Eve needs a certain
detector in Bob to produce a click, she modifies polarization (or other
parameter used to encode quantum states) of the light she sends to Bob such
that the target detector stops receiving light while the other detector(s)
continue to be illuminated. The target detector regains single photon
sensitivity and, when Eve modifies the polarization again, produces a single
click. Thus, Eve has full control of Bob and can do a successful
intercept-resend attack. To check the feasibility of the attack, 3 different
models of passively-quenched detectors have been tested. In the experiment, I
have simulated the intensity diagrams the detectors would receive in a real
quantum key distribution system under attack. Control parameters and side
effects are considered. It appears that the attack could be practically
possible.Comment: Experimental results from a third detector model added. Minor
corrections and edits made. 11 pages, 10 figure
Detection of Lyman-alpha Emitting Galaxies at Redshift z=4.55
Studies of the formation and early history of galaxies have been hampered by
the difficulties inherent in detecting faint galaxy populations at high
redshift. As a consequence, observations at the highest redshifts (3.5 < z < 5)
have been restricted to objects that are intrinsically bright. These include
quasars, radio galaxies, and some Ly alpha-emitting objects that are very close
to (within ~10 kpc) -- and appear to be physically associated with -- quasars.
But the extremely energetic processes which make these objects easy to detect
also make them unrepresentative of normal (field) galaxies. Here we report the
discovery using Keck spectroscopic observations of two Ly alpha-emitting
galaxies at redshift z = 4.55, which are sufficiently far from the nearest
quasar (~700 kpc) that radiation from the quasar is unlikely to provide the
excitation source of the Ly alpha emission. Instead, these galaxies appear to
be undergoing their first burst of star formation, at a time when the Universe
was less than one billion years old.Comment: 8 pages, 1 landscape table, and 3 PostScript figures. Uses
aaspp4.sty, flushrt.sty, aj_pt4.sty, overcite.sty (style macros available
from xxx.lanl.gov) Figure 1 is bitmapped to 100 dpi. The original PostScript
version of Fig. 1 is available via anonymous ftp to
ftp://hubble.ifa.hawaii.edu/pub/preprints To appear in Natur
The Complete Star Formation History of the Universe
The determination of the star-formation history of the Universe is a key goal
of modern cosmology, as it is crucial to our understanding of how structure in
the Universe forms and evolves. A picture has built up over recent years,
piece-by-piece, by observing young stars in distant galaxies at different times
in the past.
These studies indicated that the stellar birthrate peaked some 8 billion
years ago, and then declined by a factor of around ten to its present value.
Here we report on a new study which obtains the complete star formation history
by analysing the fossil record of the stellar populations of 96545 nearby
galaxies. Broadly, our results support those derived from high-redshift
galaxies elsewhere in the Universe. We find, however, that the peak of star
formation was more recent - around 5 billion years ago. Our study also shows
that the bigger the stellar mass of the galaxy, the earlier the stars were
formed. This striking result indicates a very different formation history for
high- and low-mass formation.Comment: Accepted by Nature. Press embargo until publishe
Implications of alternative definitions of prediabetes for prevalence in US adults
OBJECTIVE—To compare the prevalence of prediabetes using A1C, fasting plasma glucose (FPG), and oral glucose tolerance test (OGTT) criteria, and to examine the degree of agreement between the measures. RESEARCH DESIGN AND METHODS—We used the 2005–2008 National Health and Nutrition Examination Surveys to classify 3,627 adults aged 18 years was 14.2% for A1C 5.7–6.4% (A1C5.7), 26.2% for FPG 100–125 mg/dL (IFG100), 7.0% for FPG 110–125 mg/dL (IFG110), and 13.7% for OGTT 140–199 mg/dL (IGT). Prediabetes prevalence varied by age, sex, and race/ethnicity, and there was considerable discordance between measures of prediabetes. Among those with IGT, 58.2, 23.4, and 32.3% had IFG100, IFG110, and A1C5.7, respectively, and 67.1% had the combination of either A1C5.7 or IFG100. CONCLUSIONS—The prevalence of prediabetes varied by the indicator used to measure risk; there was considerable discordance between indicators and the characteristics of individuals with prediabetes. Programs to prevent diabetes may need to consider issues of equity, resources, need, and efficiency in targeting their efforts
Prevalence of diabetes mellitus and impaired glucose tolerance in a rural community of Angola
<p>Abstract</p> <p>Background</p> <p>To determine the prevalence of diabetes mellitus (DM) and impaired glucose tolerance (IGT) in a rural community (Bengo) of Angola.</p> <p>Methods</p> <p>A random sample of 421 subjects aged 30 to 69 years (30% men and 70% women) was selected from three villages of Bengo province. This cross-sectional home survey was conducted using a sampling design of stage conglomerates. First, clinical and anthropometric data were obtained and fasting capillary glucose level was determined. Subjects who screened positive (fasting capillary glucose ≥ 100 mg/dl and < 200 mg/dl) and each sixth consecutive subject who screened negative (fasting capillary glucose < 100 mg/dl) were submitted to the second phase of survey, consisting of the 75-g oral glucose tolerance test. Data was analyzed by the use of SAS statistical software.</p> <p>Results</p> <p>The prevalence rates of diabetes mellitus and IGT were 2.8% and 8.1%, respectively. The age group with the highest prevalence of diabetes was 60 to 69 years (42%). Impaired glucose tolerance prevalence was 38% in the 40 to 49 year age group and it increased with age, considering that the 50 to 59 and 60 to 69 year age groups as a whole represent 50% of all subjects with impaired glucose tolerance. The prevalence of diabetes mellitus did not differ significantly between men (3.2%) and women (2.7%) (p = 0.47). On the other hand, the prevalence of impaired glucose tolerance among women showed almost twice that found in men (9.1% vs. 5.6%, respectively). Overweight was present in 66.7% of the individuals with diabetes mellitus and 26.5% of individuals with impaired glucose tolerance showed overweight or obesity.</p> <p>Conclusions</p> <p>Although the prevalence of diabetes mellitus was low, the prevalence of impaired glucose tolerance is considered to be within an intermediary range, suggesting a future increase in the frequency of diabetes in this population.</p
Relationship Between Obesity and Diabetes in a US Adult Population: Findings from the National Health and Nutrition Examination Survey, 1999–2006
# The Author(s) 2010. This article is published with open access at Springerlink.com Background Obesity is one of the most important modifiable risk factors for the prevention of type 2 diabetes. The aim of this study was to examine the prevalence of diabetes with increasing severity of obesity and the distribution of HbA1c levels in diabetics participating in the latest National Health and Nutrition Examination Survey (NHANES). Methods Data from a representative sample of adults with diabetes participating in the NHANES between 1999 and 2006 were reviewed. The prevalence of diabetes and levels of fasting glucose, insulin, c-peptide, and HbA1c were examined across different weight classes with normal weight, overweight, and obesity classes 1, 2, and 3 were defined as body mass index (BMI) of <25.0, 25.0–29.9, 30.0–34.9, 35.0–39.9, and equal to 40.0, respectively. The distribution of HbA1c levels among adults with diabetes was also examined. Results There were 2,894 adults with diabetes (13.6%) among the 21,205 surveyed participants. Among the adults with diabetes, the mean age was 59 years, the mean fasting glucose was 155±2 mg/dl, and the mean HbA1c was 7.2%; 80.3 % of diabetics were considered overweight (BMI≥25) and 49.1 % of diabetics were considered obese (BMI≥30). Presented as a poster presentation at the American Society fo
A randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatment of type 2 diabetes with usual diabetes therapy and either Cycloset™ or placebo
Background: Cycloset™ is a quick-release formulation of bromocriptine mesylate, a dopamine agonist, which in animal models of insulin resistance and type 2 diabetes acts centrally to reduce resistance to insulin- mediated suppression of hepatic glucose output and tissue glucose disposal. In such animals, bromocriptine also reduces hepatic triglyceride synthesis and free fatty acid mobilization, manifesting decreases in both plasma triglycerides and free fatty acids. In clinical trials, morning administration of Cycloset™ either as monotherapy or adjunctive therapy to sulfonylurea or insulin reduces HbA1c levels relative to placebo by 0.55–1.2. Cycloset™ therapy also reduces plasma triglycerides and free fatty acid by approximately 25% and 20%, respectively, among those also receiving sulfonylurea therapies. The effects of once-daily morning Cycloset™ therapy on glycemic control and plasma lipids are demonstrable throughout the diurnal portion of the day (7 a.m. to 7 p.m.) across postprandial time points. Methods/Design: 3,095 individuals were randomized in a 2:1 ratio into a one year trial aimed to assess the safety and efficacy of Cycloset™ compared to placebo among individuals receiving a variety of treatments for type 2 diabetes. Eligibility criteria for this randomized placebo controlled trial included: age 30–80, HbA1c ≤ 10%, diabetes therapeutic regimen consisting of diet or no more than two hypoglycemic agents or insulin with or without one additional oral agent (usual diabetes therapy; UDT). The primary safety endpoint will test the hypothesis that the rate of all-cause serious adverse events after one year of usual diabetes therapy (UDT) plus Cycloset™ is not greater than that for UDT plus placebo by more than an acceptable margin defined as a hazard ratio of 1.5 with a secondary endpoint analysis of the difference in the rate of serious cardiovascular events, (myocardial infarction, stroke, coronary revascularization or hospitalization for or angina or congestive heart failure). Efficacy analyses will evaluate effects of Cycloset™ versus placebo on change from baseline in HbA1c, fasting glucose, body weight, waist circumference, blood pressure and plasma lipids. Discussion: This study will extend the current data on Cycloset™ safety, tolerability and efficacy in individuals with type 2 diabetes to include its effects in combination with thiazolodinediones, insulin secretagogues, metformin, alpha-glucosidase inhibitors and exogenous insulin regimens. Trial registration: clinical trials.gov NCT0037767
The effectiveness of peer health coaching in improving glycemic control among low-income patients with diabetes: protocol for a randomized controlled trial
<p>Abstract</p> <p>Background</p> <p>Although self-management support improves diabetes outcomes, it is not consistently provided in health care settings strained for time and resources. One proposed solution to personnel and funding shortages is to utilize peer coaches, patients trained to provide diabetes education and support to other patients. Coaches share similar experiences about living with diabetes and are able to reach patients within and beyond the health care setting. Given the limited body of evidence that demonstrates peer coaching significantly improves chronic disease care, this present study examines the impact of peer coaching delivered in a primary care setting on diabetes outcomes.</p> <p>Methods/Design</p> <p>The aim of this multicenter, randomized control trial is to evaluate the effectiveness of utilizing peer coaches to improve clinical outcomes and self-management skills in low-income patients with poorly controlled diabetes. A total of 400 patients from six primary health centers based in San Francisco that serve primarily low-income populations will be randomized to receive peer coaching (n = 200) or usual care (n = 200) over 6 months. Patients in the peer coach group receive coaching from patients with diabetes who are trained and mentored as peer coaches. The primary outcome is change in HbA1c. Secondary outcomes include change in: systolic blood pressure, body mass index (BMI), LDL cholesterol, diabetes self-care activities, medication adherence, diabetes-related quality of life, diabetes self-efficacy, and depression. Clinical values (HbA1c, LDL cholesterol and blood pressure) and self-reported diabetes self-efficacy and self-care activities are measured at baseline and after 6 months for patients and coaches. Peer coaches are also assessed at 12 months.</p> <p>Discussion</p> <p>Patients with diabetes, who are trained as peer health coaches, are uniquely poised to provide diabetes self management support and education to patients. This study is designed to investigate the impact of peer health coaching in patients with poorly controlled diabetes. Additionally, we will assess disease outcomes in patients with well controlled diabetes who are trained and work as peer health coaches.</p> <p>Trial Registration</p> <p>ClinicalTrials.gov identifier: <a href="http://www.clinicaltrials.gov/ct2/show/NCT01040806">NCT01040806</a></p
- …